- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04224077
Diffusion Tensor Sequences (DTI) for Study of Lumbar Roots by Magnetic Resonance Imaging (MRI) (OPTI-DTI)
Optimisation of Diffusion Tensor Sequences (DTI) for Study of Lumbar Roots by Magnetic Resonance Imaging (MRI) : a Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For every healthy volunteer will be acquired:
- a morphological sequence
- a reference diffusion tensor sequence covering three lumbar stages (reference DTI),
- a diffusion tensor sequence acquired in multiband technique, covering three lumbar stages (optimized DTI),
- a diffusion tensor sequence acquired in a multiband technique, covering a lumbar stage, of higher spatial resolution (centred DTI)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lomme, France, 59462
- Lille Catholic Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Person without history of lumbar surgery
- Person who has previously consented
Exclusion Criteria:
- MRI contraindications (pace maker, cardiac defibrillator,...)
- Claustrophobia
- Pregnant woman
- Person without social security
- Person with a guardianship
- Person carrying metallic surgical material (spine, pelvis, abdomen)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention
Healthy volunteers
|
Optimisation of DTI sequences in the study of lumbar roots by MRI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Image quality measured as signal-to-noise ratio and contrast-to-noise ratio
Time Frame: Day 0
|
Comparison of the image quality between DTI optimized and DTI of reference. The signal-to-noise ratio is a measure that compares the level of a desired signal to the level of background noise. Mathematically, the signal-to-noise ratio is the quotient of the (mean) signal intensity measured in a region of interest and the standard deviation of the signal intensity in a region outside the anatomy of the object being imaged. The contrast-to-noise ratio is a measure of image quality based on a contrast rather than the raw signal. |
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fraction of anisotropy and apparent diffusion coefficient
Time Frame: Day 0
|
Comparison of fraction of anisotropy, and apparent diffusion coefficient between DTI optimized and DTI of reference. The measurement of fraction of anisotropy, and apparent diffusion coefficient provides robust values for quantifying the degree of microstructural abnormalities of nerves. |
Day 0
|
|
Concordance of observed agreement measured by Cohen's kappa coefficient
Time Frame: Day 0
|
Evaluation of interobserver accordance for multiband acquisitions (optimized DTI)
|
Day 0
|
|
Concordance of observed agreement measured by Intra-class correlation coefficient
Time Frame: Day 0
|
Evaluation of interobserver accordance for multiband acquisitions (optimized DTI)
|
Day 0
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-François BUDZIK, MD, GHICL
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-P0060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MRI
-
Assaf-Harofeh Medical CenterRecruitingMRI, Functional MRIIsrael
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
PfizerCompletedMRI SedationUnited States, Japan
-
University of UtahWithdrawnMRI ScansUnited States
-
Rennes University HospitalRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Atridia Pty Ltd.Completed
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University of LiegeUnknown
Clinical Trials on Optimisation of DTI sequences
-
University of DundeeCompletedHeart Failure | Cardiac Resynchronisation PacemakersUnited Kingdom
-
London Health Sciences CentreUniversity of Western Ontario, Canada; London Regional Cancer Program, CanadaTerminated
-
Hvidovre University HospitalRegion Capital Denmark; Region Hovedstadens Apotek; Clinical Research Centre; Udviklings-... and other collaboratorsActive, not recruitingMalnutrition | Aging | Drug PrescribingDenmark
-
Hospices Civils de LyonCompletedPotentially Inappropriate MedicationsFrance
-
King's College LondonKing's College Hospital NHS Trust; The Leeds Teaching Hospitals NHS Trust; Guy... and other collaboratorsNot yet recruitingHeart Failure | Cardiac Resynchronisation Therapy (CRT)United Kingdom
-
Institut de cancérologie Strasbourg EuropeHôpitaux Universitaires de StrasbourgTerminatedSquamous Cell Carcinoma of Head and Neck | Oropharyngeal Squamous Cell Carcinoma | Oral Cavity Squamous Cell CarcinomaFrance
-
Roman GuggenbergerCompletedBone Diseases | Bone AnatomySwitzerland
-
Oxford University Hospitals NHS TrustCompletedCoronary Artery DiseaseUnited Kingdom
-
HEIDEGGER CPRecruitingCritical Illness | Malnutrition | ICU Acquired WeaknessSwitzerland
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance